Quotient
QTNT
$0.38
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Quotient (QTNT) - Cash on Hand
Cash on Hand as of December 2022 : $11.93 M
According to Quotient's latest financial reports the company has $11.93 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Quotient - Cash on Hand chart (from 2013 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-03-31 | $67.68 M | -39.39% |
| 2021-03-31 | $0.11 B | -7.55% |
| 2020-03-31 | $0.12 B | 27.39% |
| 2019-03-31 | $94.82 M | 267.06% |
| 2018-03-31 | $25.83 M | 24.14% |
| 2017-03-31 | $20.81 M | -52.81% |
| 2016-03-31 | $44.1 M | 17.52% |
| 2015-03-31 | $37.52 M | 421.76% |
| 2014-03-31 | $7.19 M | 70.47% |
| 2013-03-31 | $4.21 M | -3.1% |
| 2012-03-31 | $4.35 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Atossa Therapeutics ATOS | $94.03 M | 687.93% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | $18.17 M | 52.33% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $7.57 M | -36.53% | 🇺🇸 USA |